BRETT SHERIDAN STECKER

Allopathic & Osteopathic Physicians|Family Medicine RAYNHAM, MA NPI 1114097599

General Payments — all program years on this page

$2,082.77

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 114
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $440.62 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $440.6220

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $340.7711
2019 $436.0542
2020 $85.685
2021 $321.6514
2022 $193.9610
2023 $264.0412
2024 $440.6220

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087236183 Novartis Pharmaceuticals Corporation $17.85 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087236187 Novartis Pharmaceuticals Corporation $14.28 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087236189 Novartis Pharmaceuticals Corporation $13.33 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092245672 Boston Scientific Corporation $31.32 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096673887 Novo Nordisk Inc $21.07 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096948958 Novo Nordisk Inc $16.41 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097071456 Novo Nordisk Inc $27.40 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097374645 Novo Nordisk Inc $21.88 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097537235 Novo Nordisk Inc $21.86 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106156121 ABBVIE INC. $31.67 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116362139 GlaxoSmithKline, LLC. $20.98 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116665191 GlaxoSmithKline, LLC. $28.44 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124850079 Abbott Laboratories $24.77 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131116098 PFIZER INC. $19.54 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131604478 PFIZER INC. $22.98 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132027555 PFIZER INC. $18.41 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136071553 Lilly USA, LLC $21.73 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139263362 Astellas Pharma US Inc $24.59 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139399031 Astellas Pharma US Inc $24.98 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146487635 Antares Pharma, Inc. $17.13 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.